Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $5.57 Million - $6.49 Million
34,800 Added 1288.89%
37,500 $6.66 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $2.01 Million - $2.26 Million
-12,500 Reduced 82.24%
2,700 $454,000
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $2.22 Million - $2.78 Million
15,200 New
15,200 $2.62 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.61B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.